MAP2K7 and breast carcinoma: Previous studies reported that AKR1B10 increased the synthesis of the lipid second messengers PIP2 and DAG in breast cancer cells, activating the Raf/MEK/ERK signalling pathway and promoting cancer cell proliferation 34.